Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTP273 in Adults With Type 2 Diabetes Mellitus
CTR20202349Phase 2Terminated
- Sponsor
- Huadong Medicine
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ttp273 in type 2 diabetes mellitus (T2DM), sponsored by Huadong Medicine. Started Nov 2020; status: terminated.
02
Drugs
ttp273
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20202349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202349.